The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/38128
StudyName: Eligibility Breast Cancer NCT01810393
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 20.09.2019
License: Creative Commons BY 4.0

----

Description: 
A Study of Patient Preference for Subcutaneous Versus Intravenous Herceptin (Trastuzumab) in Patients With HER2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Herceptin for at Least 3 Years; ODM derived from: https://clinicaltrials.gov/show/NCT01810393
